» Articles » PMID: 38725401

Outcomes of Partially Covered Self-expandable Metal Stents with Different Uncovered Lengths in Endoscopic Ultrasound-guided Hepaticogastrostomy: a Japanese Retrospective Study

Abstract

Background/aims: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO).

Methods: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared.

Results: Sixty-two patients underwent EUS-HGS using PCSEMS (5/20-mm uncovered portions: 32/30). Stent migration occurred only in the 5-mm group. There were no differences in RBO rates (28.1% vs. 40.0%) or median time to RBO (6.8 vs. 7.1 months) between the two groups. Median overall survival (OS) was longer in the 20-mm group (3.1 vs. 4.9 months, p=0.037) due to the higher number of patients that resumed chemotherapy after EUS-HGS (56.7% vs. 28.1%, p=0.029). Good performance status, absence of hepatic metastases, and chemotherapy after EUS-HGS were independent predictors of longer OS.

Conclusions: No migration was observed in patients treated with PCSEMS with 20-mm uncovered portions. Patients treated with PCSEMS with 20-mm uncovered portions performed at least as well as those treated with 5-mm uncovered portions in all material respects.

Citing Articles

Migration of covered expandable metal stents after endoscopic ultrasound-guided hepaticogastrostomy: stent covering versus stent design?.

Baron T Clin Endosc. 2024; 57(4):471-472.

PMID: 39075974 PMC: 11294865. DOI: 10.5946/ce.2024.158.

References
1.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

2.
Wang K, Zhu J, Xing L, Wang Y, Jin Z, Li Z . Assessment of efficacy and safety of EUS-guided biliary drainage: a systematic review. Gastrointest Endosc. 2015; 83(6):1218-27. DOI: 10.1016/j.gie.2015.10.033. View

3.
Cho D, Lee S, Oh D, Song T, Park D, Seo D . Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos). Gastrointest Endosc. 2016; 85(5):1067-1075. DOI: 10.1016/j.gie.2016.09.010. View

4.
Attasaranya S, Netinasunton N, Jongboonyanuparp T, Sottisuporn J, Witeerungrot T, Pirathvisuth T . The Spectrum of Endoscopic Ultrasound Intervention in Biliary Diseases: A Single Center's Experience in 31 Cases. Gastroenterol Res Pract. 2012; 2012:680753. PMC: 3357930. DOI: 10.1155/2012/680753. View

5.
Bories E, Pesenti C, Caillol F, Lopes C, Giovannini M . Transgastric endoscopic ultrasonography-guided biliary drainage: results of a pilot study. Endoscopy. 2007; 39(4):287-91. DOI: 10.1055/s-2007-966212. View